Fundraising Fox
Hexagon Bio
Menlo Park, US · Founded 2016 · 77 employees on LinkedIn · 9 known investors
Find your way into Hexagon Bio
Sign up to see every warm intro you have to Hexagon Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hexagon Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hexagon Bio develops novel payload mechanisms for antibody-drug conjugates (ADCs) aimed at overcoming resistance to current cancer treatments and expanding ADC indications. The company focuses on targeted cytotoxic therapy for cancer, drawing on human therapeutics derived from metagenomes.
Founders & leadership
Hexagon Bio was founded in 2016 by Colin James Bell Harvey, Brian T. Naughton, and Maureen Hillenmeyer.
Board
Investors · 9
How we know: ATEL Ventures's portfolio page · Not right? Tell us
How we know: Nextech Invest's portfolio page · a partner's Signal profile · funding news · hexagonbio.com · Not right? Tell us
How we know: The Column Group's portfolio page · a partner's Signal profile · board seat on SEC Form D · funding news · hexagonbio.com · the VCSheet dataset · Not right? Tell us
How we know: board seat on SEC Form D · funding news · hexagonbio.com · the VCSheet dataset · Not right? Tell us
How we know: funding news · hexagonbio.com · Not right? Tell us
How we know: a partner's Signal profile · funding news · hexagonbio.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$148.6M disclosed across 4 of 6 rounds · 2017–2022
- Undisclosed amountSeries ASep 2020
The Column Group (lead), 8VC, Two Sigma Ventures
Source ↗
▶$67.3MraisedOct 2022 · 20 investors · BiotechnologyRule 506(b)
- Juan JaenDirector
- Alex KolicichDirector
- Jakob LovenDirector
- Brian T NaughtonExecutive Officer, Director
- David GoeddelDirector
- Mridula RayDirector
- Maureen E HillenmeyerExecutive Officer, Director
- Offering amount
- $80M
- Amount sold
- $67.3M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$61MraisedJul 2021 · 14 investors · BiotechnologyRule 506(b)
- Maureen HillenmeyerExecutive Officer, Director
- David GoeddelDirector
- Brian NaughtonExecutive Officer, Director
- Juan JaenDirector
- Mridula RayDirector
- Jakob LovenDirector
- Alex KolicichDirector
- Amount sold
- $61M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$12MraisedJul 2018 · 12 investors · BiotechnologyRule 506(b)
- Brian T. NaughtonExecutive Officer, Director
- Colin James Bell HarveyExecutive Officer, Director
- Alex KolicichDirector
- Maureen E. HillenmeyerExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$8.3MraisedJul 2017 · 9 investors · BiotechnologyRule 506(b)
- Colin James Bell HarveyDirector
- Alex KolichDirector
- Brian T. NaughtonDirector
- Maureen E. HillenmeyerExecutive Officer, Director
- Offering amount
- $8.4M
- Amount sold
- $8.3M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Hexagon Bio.
In the news
Frequently asked questions
- What does Hexagon Bio do?
- Hexagon Bio develops novel payload mechanisms for antibody-drug conjugates (ADCs) aimed at overcoming resistance to current cancer treatments and expanding ADC indications. The company focuses on targeted cytotoxic therapy for cancer, drawing on human therapeutics derived from metagenomes.
- Who founded Hexagon Bio?
- Hexagon Bio was founded by Colin James Bell Harvey, Brian T. Naughton, Maureen Hillenmeyer in 2016.
- Who are Hexagon Bio's investors?
- Hexagon Bio's investors include ATEL Ventures, B3 Holding, Nextech Invest, SoftBank Vision Fund, The Column Group, 8VC, Casdin Capital, Two Sigma Ventures.
- How much funding has Hexagon Bio raised?
- Hexagon Bio has disclosed $148.6M raised across 4 of its 6 known rounds.
- Where is Hexagon Bio headquartered?
- Hexagon Bio is headquartered in Menlo Park, US.